---
figid: PMC6748114__41418_2019_317_Fig4_HTML
figlink: pmc/articles/PMC6748114/figure/Fig4/
number: Fig. 4
caption: Inhibition of Gal-1 by OTX008 results in HRAS mistargeting to the cell membrane,
  leading to the blockage of mitogen-activated protein kinase mitogenic pathway, whereas
  rapamycin decreases mammalian target of rapamycinsurvival signaling. Combination
  of OTX008 and rapamycin yields more effective treatment against tumor progression.
  Blockage of Gal-3 with MCP/GSC-100 activates caspase-8 and -9 pathways and induces
  NOXA protein, leading to decrease in MCL-1 and BCL-XL. Inhibition of nuclear Gal-3
  induces cell-cycle inhibitor p21Cip1 expression and blocks the expression of cyclins,
  leading to cell death. Inhibition of Gal-3 with MCP/GSC-100 reduces KRAS-activated
  tumor progression. The combined treatment using MCP/GCS-100 and rapamycin together,
  however, has revealed more promising results in the KRAS mutant tumor progression
  experimental models. Figure is modified from []
pmcid: PMC6748114
papertitle: 'Decoding the sweet regulation of apoptosis: the role of glycosylation
  and galectins in apoptotic signaling pathways.'
reftext: Kamil Seyrek, et al. Cell Death Differ. 2019 Jun;26(6):981-993.
pmc_ranked_result_index: '54128'
pathway_score: 0.9407651
filename: 41418_2019_317_Fig4_HTML.jpg
figtitle: 'Decoding the sweet regulation of apoptosis: the role of glycosylation and
  galectins in apoptotic signaling pathways'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6748114__41418_2019_317_Fig4_HTML.html
  '@type': Dataset
  description: Inhibition of Gal-1 by OTX008 results in HRAS mistargeting to the cell
    membrane, leading to the blockage of mitogen-activated protein kinase mitogenic
    pathway, whereas rapamycin decreases mammalian target of rapamycinsurvival signaling.
    Combination of OTX008 and rapamycin yields more effective treatment against tumor
    progression. Blockage of Gal-3 with MCP/GSC-100 activates caspase-8 and -9 pathways
    and induces NOXA protein, leading to decrease in MCL-1 and BCL-XL. Inhibition
    of nuclear Gal-3 induces cell-cycle inhibitor p21Cip1 expression and blocks the
    expression of cyclins, leading to cell death. Inhibition of Gal-3 with MCP/GSC-100
    reduces KRAS-activated tumor progression. The combined treatment using MCP/GCS-100
    and rapamycin together, however, has revealed more promising results in the KRAS
    mutant tumor progression experimental models. Figure is modified from []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - PMAIP1
  - RAF1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAP2K1
  - MAPK3
  - MAPK1
  - Rapamycin
genes:
- word: HRAS
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NOXA
  symbol: NOXA
  source: hgnc_alias_symbol
  hgnc_symbol: PMAIP1
  entrez: '5366'
- word: RAF-1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAF-1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: МЕК-1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK-1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
---
